September/October 2009, Vol 2, No 6

Regulatory

Predictive and Prognostic Models: Implications for Healthcare Decision-Making in a Modern Recession
F. Randy Vogenberg, RPh, PhD
Stakeholder Perspective by Jason Roy, PhD

Clinical

Estimates of Commercial Population at High Risk for Cardiovascular Events: Impact of Aggressive Cholesterol Reduction
Kathryn Fitch, RN, MEd
; Sara W. Goldberg, FSA, MAAA
; Kosuke Iwasaki, FIAJ, MAAA
; Bruce S. Pyenson, FSA, MAAA
; Andreas Kuznik, PhD
; Henry A. Solomon, FACP, FACC
Stakeholder Perspective by David Williams

Business

Impact of Prescription Benefit Coverage Limits on Sevelamer Hydrochloride Adherence for Patients with ESRD
Bharati Bhardwaja, PharmD, BCPS
; Nikki Carroll, MS
; Eli Korner, PharmD
; Kavita V. Nair, PhD
Stakeholder Perspective by Jack E. Fincham, PhD, RPh
Private Health Plans Perspectives: Electronic Personal Health Records and Electronic Prescribing
Nancy M. McGee, JD, MPH
; Gene Reeder, RPh, PhD
; Timothy S. Regan, BPharm, RPh, CPh
; J.D. Kleinke
; Steve Arnold, MD, MS, MBA, CPE
Stakeholder Perspective by Gary M. Owens, MD

Commentary

Cost-Sharing Enhances Cost Control
Government Health Plans Always Ration Care: Europe Offers a Glimpse of the Future If President Obama and Congressional Democrats Have Their Way
Scott Gottlieb, MD

Point and Counterpoint

Healthcare Reform, Classicism, and How We Treat the Elderly: The Politics of Epidemiology
Robert E. Henry

Generic Drug Trends

Can Generics Help Heal Our Ailing Healthcare System?
Dalia Buffery, MA, ABD